메뉴 건너뛰기




Volumn 22, Issue 12, 2015, Pages 3831-3835

Characterizing Breast Cancer in a Population with Increased Prevalence of Triple-Negative Breast Cancer: Androgen Receptor and ALDH1 Expression in Ghanaian Women

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; ANDROGEN RECEPTOR; CELL MARKER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; FORMALDEHYDE; PARAFFIN; PROGESTERONE RECEPTOR; ERBB2 PROTEIN, HUMAN; ISOENZYME; RETINAL DEHYDROGENASE;

EID: 84943355856     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4455-x     Document Type: Article
Times cited : (26)

References (22)
  • 1
    • 28344454000 scopus 로고    scopus 로고
    • Molecular classification and molecular forecasting of breast cancer: ready for clinical application?
    • COI: 1:CAS:528:DC%2BD2MXhtF2nsLrJ, PID: 16145060
    • Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol. 2005;23(29):7350-7360.
    • (2005) J Clin Oncol. , vol.23 , Issue.29 , pp. 7350-7360
    • Brenton, J.D.1    Carey, L.A.2    Ahmed, A.A.3    Caldas, C.4
  • 2
    • 0034680102 scopus 로고    scopus 로고
    • Molecular portraits of human breast tumours
    • COI: 1:CAS:528:DC%2BD3cXmt1CnsLw%3D, PID: 10963602
    • Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747-752.
    • (2000) Nature. , vol.406 , Issue.6797 , pp. 747-752
    • Perou, C.M.1    Sorlie, T.2    Eisen, M.B.3
  • 3
    • 84901586809 scopus 로고    scopus 로고
    • Basal-like and triple-negative breast cancers: searching for positives among many negatives
    • PID: 24882351
    • Alluri P, Newman LA. Basal-like and triple-negative breast cancers: searching for positives among many negatives. Surg Oncol Clin N Am. 2014;23(3):567-577.
    • (2014) Surg Oncol Clin N Am. , vol.23 , Issue.3 , pp. 567-577
    • Alluri, P.1    Newman, L.A.2
  • 4
    • 79959503213 scopus 로고    scopus 로고
    • Triple-negative breast cancer: an unmet medical need
    • PID: 21278435
    • Hudis CA, Gianni L. Triple-negative breast cancer: an unmet medical need. Oncologist. 2011;16 Suppl 1:1-11.
    • (2011) Oncologist. , vol.16 , pp. 1-11
    • Hudis, C.A.1    Gianni, L.2
  • 5
    • 79960015997 scopus 로고    scopus 로고
    • Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
    • COI: 1:CAS:528:DC%2BC3MXovVKgu78%3D, PID: 21633166
    • Lehmann BD, Bauer JA, Chen X, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–67.
    • (2011) J Clin Invest. , vol.121 , Issue.7 , pp. 2750-2767
    • Lehmann, B.D.1    Bauer, J.A.2    Chen, X.3
  • 6
    • 84864579879 scopus 로고    scopus 로고
    • TNBC type: a subtyping tool for triple-negative breast cancer
    • PID: 22872785
    • Chen X, Li J, Gray WH, et al. TNBC type: a subtyping tool for triple-negative breast cancer. Cancer Inform. 2012;11:147-156.
    • (2012) Cancer Inform. , vol.11 , pp. 147-156
    • Chen, X.1    Li, J.2    Gray, W.H.3
  • 7
    • 84886412350 scopus 로고    scopus 로고
    • Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes
    • COI: 1:CAS:528:DC%2BC3sXhsFynsL7P, PID: 23948975
    • Masuda H, Baggerly KA, Wang Y, et al. Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes. Clin Cancer Res. 2013;19(19):5533-5540.
    • (2013) Clin Cancer Res. , vol.19 , Issue.19 , pp. 5533-5540
    • Masuda, H.1    Baggerly, K.A.2    Wang, Y.3
  • 8
    • 84880379664 scopus 로고    scopus 로고
    • The role of the androgen receptor in triple-negative breast cancer
    • COI: 1:CAS:528:DC%2BC3sXhtVGltLjL, PID: 23826776
    • Shah PD, Gucalp A, Traina TA. The role of the androgen receptor in triple-negative breast cancer. Womens Health (Lond Engl). 2013;9(4):351-360.
    • (2013) Womens Health (Lond Engl). , vol.9 , Issue.4 , pp. 351-360
    • Shah, P.D.1    Gucalp, A.2    Traina, T.A.3
  • 10
    • 84896702428 scopus 로고    scopus 로고
    • Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype
    • PID: 24046116
    • McGhan LJ, McCullough AE, Protheroe CA, et al. Androgen receptor-positive triple negative breast cancer: a unique breast cancer subtype. Ann Surg Oncol. 2014;21(2):361–7.
    • (2014) Ann Surg Oncol. , vol.21 , Issue.2 , pp. 361-367
    • McGhan, L.J.1    McCullough, A.E.2    Protheroe, C.A.3
  • 11
    • 84886425456 scopus 로고    scopus 로고
    • Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer
    • COI: 1:CAS:528:DC%2BC3sXhsFynsL7M, PID: 23965901
    • Gucalp A, Tolaney S, Isakoff SJ, et al. Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clin Cancer Res. 2013;19(19):5505-5512.
    • (2013) Clin Cancer Res. , vol.19 , Issue.19 , pp. 5505-5512
    • Gucalp, A.1    Tolaney, S.2    Isakoff, S.J.3
  • 12
    • 77149129286 scopus 로고    scopus 로고
    • Triple-negative breast cancer: role of the androgen receptor
    • COI: 1:CAS:528:DC%2BC3cXjvVKktL0%3D, PID: 20164692
    • Gucalp A, Traina TA. Triple-negative breast cancer: role of the androgen receptor. Cancer J. 2010;16(1):62-65.
    • (2010) Cancer J. , vol.16 , Issue.1 , pp. 62-65
    • Gucalp, A.1    Traina, T.A.2
  • 13
    • 84863795169 scopus 로고    scopus 로고
    • Triple-negative breast cancer: adjuvant therapeutic options
    • PID: 22312556
    • Gucalp A, Traina TA. Triple-negative breast cancer: adjuvant therapeutic options. Chemother Res Pract. 2011;2011:696208.
    • (2011) Chemother Res Pract. , vol.2011 , pp. 696208
    • Gucalp, A.1    Traina, T.A.2
  • 14
    • 84890254448 scopus 로고    scopus 로고
    • Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update
    • PID: 24101045
    • Wolff AC, Hammond ME, Hicks DG, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. J Clin Oncol. 2013;31(31):3997-4013.
    • (2013) J Clin Oncol. , vol.31 , Issue.31 , pp. 3997-4013
    • Wolff, A.C.1    Hammond, M.E.2    Hicks, D.G.3
  • 15
    • 77954526150 scopus 로고    scopus 로고
    • American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer
    • PID: 20404251
    • Hammond ME, Hayes DF, Dowsett M, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010;28(16):2784-2795.
    • (2010) J Clin Oncol. , vol.28 , Issue.16 , pp. 2784-2795
    • Hammond, M.E.1    Hayes, D.F.2    Dowsett, M.3
  • 16
    • 84921411055 scopus 로고    scopus 로고
    • The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1alpha-/VEGF-signaling
    • von Wahlde MK, Hulsewig C, Ruckert C, Götte M, Kiesel L, Bernemann C. The anti-androgen drug dutasteride renders triple negative breast cancer cells more sensitive to chemotherapy via inhibition of HIF-1alpha-/VEGF-signaling. Gynecol Endocrinol. 2015;31(2):160–4.
    • (2015) Gynecol Endocrinol. , vol.31 , Issue.2 , pp. 160-164
    • von Wahlde, M.K.1    Hulsewig, C.2    Ruckert, C.3    Götte, M.4    Kiesel, L.5    Bernemann, C.6
  • 17
    • 35848955428 scopus 로고    scopus 로고
    • ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome
    • COI: 1:CAS:528:DC%2BD2sXhsVahtrvF, PID: 18371393
    • Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell. 2007;1(5):555-567.
    • (2007) Cell Stem Cell. , vol.1 , Issue.5 , pp. 555-567
    • Ginestier, C.1    Hur, M.H.2    Charafe-Jauffret, E.3
  • 18
    • 84876420770 scopus 로고    scopus 로고
    • Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation
    • COI: 1:CAS:528:DC%2BC3sXlvVCjs7o%3D, PID: 23373898
    • McNamara KM, Yoda T, Miki Y, et al. Androgenic pathway in triple negative invasive ductal tumors: its correlation with tumor cell proliferation. Cancer Sci. 2013;104(5):639-646.
    • (2013) Cancer Sci. , vol.104 , Issue.5 , pp. 639-646
    • McNamara, K.M.1    Yoda, T.2    Miki, Y.3
  • 19
    • 84896710159 scopus 로고    scopus 로고
    • Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer
    • COI: 1:CAS:528:DC%2BC2cXjvV2jtb4%3D, PID: 23929266
    • Thike AA, Yong-Zheng Chong L, Cheok PY, et al. Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer. Mod Pathol. 2014;27(3):352–60.
    • (2014) Mod Pathol. , vol.27 , Issue.3 , pp. 352-360
    • Thike, A.A.1    Yong-Zheng Chong, L.2    Cheok, P.Y.3
  • 20
    • 78249243445 scopus 로고    scopus 로고
    • African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study
    • PID: 20629078
    • Stark A, Kleer CG, Martin I, et al. African ancestry and higher prevalence of triple-negative breast cancer: findings from an international study. Cancer. 2010;116(21):4926-4932.
    • (2010) Cancer. , vol.116 , Issue.21 , pp. 4926-4932
    • Stark, A.1    Kleer, C.G.2    Martin, I.3
  • 21
    • 84872914956 scopus 로고    scopus 로고
    • Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women
    • COI: 1:CAS:528:DC%2BC3sXhsVWrsr0%3D, PID: 22930220
    • Schwartz T, Stark A, Pang J, et al. Expression of aldehyde dehydrogenase 1 as a marker of mammary stem cells in benign and malignant breast lesions of Ghanaian women. Cancer. 2013;119(3):488-494.
    • (2013) Cancer. , vol.119 , Issue.3 , pp. 488-494
    • Schwartz, T.1    Stark, A.2    Pang, J.3
  • 22
    • 84892632994 scopus 로고    scopus 로고
    • Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis
    • Vera-Badillo FE, Templeton AJ, de Gouveia P, et al. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(1):djt319.
    • (2014) J Natl Cancer Inst. , vol.106 , Issue.1 , pp. 319
    • Vera-Badillo, F.E.1    Templeton, A.J.2    de Gouveia, P.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.